FAISAL MALIK: Open Payments
NPI 1114346244 · MANHASSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 35 payments from 9 companies in 2025. Trend: 2023 $618 · 2024 $1,184 · 2025 $1,298
Food & beverage: $1,298
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 10 | $389 |
| Averitas Pharma Inc. | 3 | $296 |
| BIOTRONIK NRO, Inc. | 2 | $182 |
| PROTEGA PHARMACEUTIALS INC | 7 | $140 |
| Forte Bio-Pharma LLC | 4 | $109 |
| Collegium Pharmaceutical, Inc. | 4 | $88 |
| Valinor Pharma, LLC | 3 | $57 |
| SCILEX PHARMACEUTICALS INC. | 1 | $22 |
| Lundbeck LLC | 1 | $14 |
Products named: General - Pain Management, QUTENZA, Prospera, ROXYBOND, PROLATE, Belbuca, MOVANTIK, Intracept.
Industry payments across NY — which companies pay providers there.
